Immunocorp Animal Health AS secures major research contract

18-Aug-2008

Immunocorp Animal Health AS (IAH), a wholly owned subsidiary of Biotec Pharmacon ASA, has been awarded a major research and development contract by the European Commission. The contract will be undertaken by nine partners from Norway, the Netherlands, Denmark, England, Germany and Poland and is entitled "Training network on protective immune modulation in warm water fish by feeding glucans".The contract has been issued under the European Union's Seventh Framework Programme (FP7) for research and technological development and has a total remit of NOK 24 million (EUR 3 million) over four years.

The research project will be based upon applications with the IAH glucan product MacroGard®. MacroGard® is currently sold as an ingredient in animal feed to strengthen the innate immune system. The research contract will enable the company to document new applications for MacroGard®.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances